CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Public ClinicalTrials.gov record NCT01227577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-arm, Open-label, Multi-center Study of Complete Molecular Response (CMR) in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Study identification
- NCT ID
- NCT01227577
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 128 participants
Conditions and interventions
Interventions
- Nilotinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2010
- Primary completion
- Oct 31, 2014
- Completion
- Oct 31, 2014
- Last update posted
- Feb 7, 2016
2010 – 2014
United States locations
- U.S. sites
- 32
- U.S. states
- 21
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Providence St. Joseph Medical Center Roy&Patricia Disney Fam Cancer | Burbank | California | 91505-6866 | — |
| Bay Area Cancer Research Dept.ofBayAreaCancerResearch | Concord | California | 94520 | — |
| St. Jude Heritage Medical Group Virginia Crosson Cancer Center | Yorba Linda | California | 92886 | — |
| Sarah Cannon Research Institute SCRI | Jacksonville | Florida | 32256 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Pasco Hernando Oncology | New Port Richey | Florida | 34652 | — |
| Georgia Regents University MedCollege of GA Cancer Ctr 2 | Augusta | Georgia | 30912 | — |
| Stroger Cook County Hospital Division of Hematology & Onc | Chicago | Illinois | 60612 | — |
| Louis A. Weiss Memorial Hospital | Chicago | Illinois | 60640 | — |
| Indiana Blood and Marrow Institute | Beach Grove | Indiana | 46107 | — |
| Cancer Center of Kansas | Witchita | Kansas | 67214-3728 | — |
| LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center(3) | New Orleans | Louisiana | 70115 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| St. Louis University Cancer Center | St Louis | Missouri | 63110 | — |
| University of Nebraska Medical Center University of Nebraska Med Ctr | Omaha | Nebraska | 68198 | — |
| Hackensack University Medical Center Dept.of HackensackUniv.MedCtr. | Hackensack | New Jersey | 07601 | — |
| University of Rochester Medical Ct James P Wilmot Cancer Ctr | Rochester | New York | 14642 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Duke University Medical Center Duke University Med Ctr | Durham | North Carolina | 27710 | — |
| Oregon Health & Science University | Portland | Oregon | 97201 | — |
| Cancer Centers of the Carolinas Cancer Center | Greenville | South Carolina | 29605 | — |
| Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology | Chattanooga | Tennessee | 37404 | — |
| The Jones Clinic | Germantown | Tennessee | 38138 | — |
| Tennessee Oncology Sarah Cannon Research Inst. | Nashville | Tennessee | 37203 | — |
| Baylor Research Institute Baylor Research Institute (17) | Dallas | Texas | 75204 | — |
| Oncology Consultants Oncology Consultants, P.A. | Houston | Texas | 77024 | — |
| Millennium Oncology | Houston | Texas | 77090 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
| Providence Regional Cancer Partnership | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01227577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2016 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01227577 live on ClinicalTrials.gov.